Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Evolve BioSystems

Evolve BioSystems
2012 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Series C LATEST DEAL TYPE
$40M LATEST DEAL AMOUNT
11 INVESTORS
Description

Developer of microbiome-based products designed to develop the next generation of products to establish, restore and maintain a healthy gut microbiome. The company's platform focuses on solving the gut dysbiosis throughout the human life cycle as well as in various animal species, enabling physicians to maintain the healthy gut microbiome in newborn infants with a consumer-directed home use product, and a hospital-based neonatal ICU product.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare
Other Healthcare Services
Primary Office
  • 2121 2nd Street
  • Suite C108
  • Davis, CA 95618
  • United States

+1 (530) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Evolve BioSystems’s full profile, request a free trial.

Evolve BioSystems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 12-Jun-2018 $40M 0000 00000 Completed Generating Revenue/Not Profitable
4. Early Stage VC (Series B) 30-May-2017 0000 0000 0000 Completed Generating Revenue/Not Profitable
3. Early Stage VC (Series A) 17-Aug-2015 000 0000 0000 Completed Startup
2. Seed Round 15-Sep-2014 $1M $1M 00.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Evolve BioSystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 2,091,709 $0.000100 $0.34 $4.3 $4.8 1x $4.3 14.64%
Seed 725,098 $0.000100 $0.11 $1.32 $1.48 1x $1.32 5.07%
To view this company’s complete Cap Table, request access »

Evolve BioSystems Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Finch Therapeutics Venture Capital-Backed Somerville, MA 00 00000 00000000000 00000
0000000000 000000 Venture Capital-Backed York, United Kingdom 0 00.000 000000000 00.000
000000 Venture Capital-Backed San Jose, CA 0 00.000 00000 00.000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
000000 Formerly VC-backed San Francisco, CA 000 00000 0000000000.
To view this company’s complete list of competitors, request access »

Evolve BioSystems Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Arla Foods Corporation Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Continental Grain Company Corporation Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Acre Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Evolve BioSystems Executive Team (12)

Name Title Board
Seat
Contact
Info
Timothy Brown Chief Executive Officer & Board Member
Sandy Argabrite Chief Financial Officer
David Kyle Ph.D Co-Founder , Executive Chairman & Chief Scientific Officer
Samara Freeman Ph.D Co-Founder & Director, Intellectual Property & Regulatory Affairs
Christie Fleming Senior Vice President of Marketing

7 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

Evolve BioSystems Board Members (10)

Name Representing Role Since Contact
Info
Daniel Janney Alta Partners Board Member 000 0000
David Kyle Ph.D Evolve BioSystems Co-Founder , Executive Chairman & Chief Scientific Officer 000 0000
Gareth Asten Acre Venture Partners Board Member 000 0000
Patrick Zhang Horizons Ventures Board Member 000 0000
Roger Wyse Ph.D Spruce Capital Partners Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »